Ligne de temps

Ingrid Fert
																												Ingénieur(e) de Recherche
																	04 juil. 2025
								publication
									Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.
Lire plus10 juin 2024
								publication
									T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Lire plus07 sept. 2023
								publication
									Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Lire plus14 sept. 2022
								publication
									A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Lire plus27 avr. 2022
								publication
									An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Lire plus07 déc. 2021
								publication
									Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Lire plus29 juil. 2021
								
							01 janv. 2021
								publication
									Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study.
Lire plus16 juil. 2015